BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 63 filers reported holding BOLT BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,648 | -10.7% | 111,200 | +9.9% | 0.00% | 0.0% |
| Q2 2023 | $129,536 | +23.9% | 101,200 | +34.6% | 0.00% | 0.0% |
| Q1 2023 | $104,528 | -57.1% | 75,200 | -59.9% | 0.00% | -50.0% |
| Q4 2022 | $243,880 | +45.2% | 187,600 | +65.7% | 0.01% | +50.0% |
| Q3 2022 | $168,000 | +25.4% | 113,200 | +72.8% | 0.00% | +33.3% |
| Q2 2022 | $134,000 | -57.6% | 65,500 | -43.3% | 0.00% | -50.0% |
| Q1 2022 | $316,000 | – | 115,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $23,927,000 | 8.46% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $14,762,000 | 4.72% |
| Novo Holdings A/S | 4,503,991 | $56,975,000 | 2.95% |
| Vivo Capital, LLC | 3,871,291 | $48,972,000 | 2.20% |
| Sofinnova Investments, Inc. | 2,754,437 | $34,844,000 | 2.06% |
| Samsara BioCapital, LLC | 737,459 | $9,329,000 | 1.46% |
| Ally Bridge Group (NY) LLC | 257,267 | $3,254,000 | 0.96% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $9,102,000 | 0.68% |
| Rock Springs Capital Management LP | 1,649,248 | $20,863,000 | 0.44% |
| RA Capital Management | 2,378,325 | $30,086,000 | 0.42% |